newsfilter
← Latest News
GlobeNewswire·

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Joseph Hulihan, MD, MSHP, brings substantial clinical development experience advancing novel therapies for TSC-related epilepsy and other neurological disordersClinical study for simufilam in TSC-related epilepsy